Syndeio Biosciences

Biotechnology Research • Indianapolis, Indiana, United States • 11-20 Employees

Company overview

Headquarters	Indianapolis, Indiana, United States
Website	syndeio.bio
NAICS	541714
Founded	2025
Employees	11-20
Socials

Key Contacts at Syndeio Biosciences

Michael G. Mccully

Co-Founder, President & Chief Operating Officer

Mark Smith

Director Cmc

Chris Burkhardt

Senior Director, Finance

Kelly O'Rourke-Kosko

Project Director, Clinical Development Operations

John Carlins

Sr. Director Clinical Science

Syndeio Biosciences Email Formats

Syndeio Biosciences uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@syndeio.bio), used 78.9% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@syndeio.bio	78.9%
{first initial}.{last name}	j.doe@syndeio.bio	21.1%

About Syndeio Biosciences

Syndeio Biosciences (from the Ancient Greek word “to connect”) is a clinical-stage biotechnology company developing therapies to restore and enhance synaptic health in CNS disorders. The company’s proprietary Boost™ Synapse Pharmacology Platform combines electrophysiology, behavior, and human neuronal network assays to predict clinical outcomes with unprecedented accuracy. Syndeio’s clinical pipeline includes lead asset, zelquistinel, currently in Phase 2 development for major depressive disorder and will soon be entering an industry-first biomarker study in Alzheimer’s disease, and apimostinel, currently in an investigator-led phase 2 study for acute depression. The company is headquartered in Indianapolis, IN with research laboratories in Menlo Park, CA & Evanston, IL focused on advancing the Boost™ Synapse Pharmacology Platform.

Syndeio Biosciences revenue & valuation

Annual revenue	$1,711,100
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,500,000
Total funding	$90,000,000

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

Senior

Entry

Employees by Department

Syndeio Biosciences has 6 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Syndeio Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2025-06-27	1	$90,000,000

Funding Insights

$90,000,000

Total funding amount

$90,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Syndeio Biosciences is located in Indianapolis, Indiana, US.

Syndeio Biosciences was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.

Syndeio Biosciences has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Syndeio Biosciences has raised a total of $90,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.